
Radio Advisory 288: Health policy update: VBC, site-neutral payments, and 340B
6 snips
Mar 3, 2026 Chloe Bakst, pharmacy policy pro focused on 340B program dynamics and drug pricing. Nick Hula, payment policy analyst who tracks site-neutral payments and inpatient-list shifts. Claire Wirth, value-based care strategist decoding new CMMI models. They discuss the surge in value-based payment models, site-of-care and payment alignment changes, and the chaotic, rapidly evolving 340B policy landscape.
AI Snips
Chapters
Transcript
Episode notes
ACCESS Opens Medicare To Tech Chronic Care
- ACCESS invites tech vendors to provide reimbursed tech-enabled chronic disease management across common conditions.
- It's a 10-year model covering diabetes, MSK, behavioral health, hypertension and similar high-prevalence conditions.
Site Neutral Could Expand Beyond Drug Admin
- Site-neutral payment aligns HOPD outpatient reimbursements with office rates and could expand beyond drug admin to imaging and procedures.
- CMS has already extended site-neutral rules to drug administration in some outpatient departments.
Inpatient Only List Phase Out Accelerates Shifts
- The inpatient-only list is being phased out over three years, with many musculoskeletal codes removed Jan 1, 2026.
- Removing the list creates opportunities to reimburse procedures in outpatient settings and drive experimentation.
